Lv3
370 积分 2022-05-08 加入
Advancing rheumatic disease care through generative artificial intelligence
10个月前
已关闭
Therapies for myasthenia gravis: FcRn inhibition and beyond
10个月前
已完结
Therapies for myasthenia gravis: FcRn inhibition and beyond
10个月前
已完结
FcRn: the neonatal Fc receptor comes of age
10个月前
已完结
Myasthenia gravis: the future is here
10个月前
已完结
Rituximab treatment of myasthenia gravis: A systematic review
10个月前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
10个月前
已完结
Chemical synthesis and characterisation of the complement C5 inhibitory peptide zilucoplan
10个月前
已完结
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndrome
10个月前
已完结
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
10个月前
已完结
皖公网安备34019202002308
